Come up with a name for your new list and we'll add to it:
OcuCure Therapeutics raised a round of funding on , . Investors include
Carilion Biomedical Institute.
OcuCure Therapeutics is an ophthalmic pharmaceutical company developing new drugs. The company's lead compound has been formulated as a topical eye drop for both Age-related Macular Degeneration (AMD)…